Nicotine Patch as an Adjunctive Intervention to Reduce Secondhand Smoke Among NICU Families

• Status: Completed
• Trial end date: 2018-06-28
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study was to explore the potential for directly targeting smoking cessation, regardless of motivation level, in a subsample of neonatal intensive care unit (NICU) parents with the ultimate goal of reducing secondhand smoke (SHS) in their homes.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: The University of Texas Health Science Center, Houston
• Treatments: Nicotine

Criteria

Inclusion Criteria:

• Eligible mothers of any age or ethnic background must have an infant that is at least 1 week prior to the estimated date of hospital discharge in the NICU (ensuring time for the intervention)

• report that a household resident smokes at least 5 cigarettes per day, on average, within the 2 months preceding the screening visit

• agree to attend intervention sessions

• live within 50 miles of our center

• and have access to a telephone

Exclusion Criteria:

• Mothers were ineligible if they met criteria for severe cognitive, and/or psychiatric impairment, per judgment of NICU and research staff, that precludes cooperation with study protocol

• were unable to read, write, and speak English

• were unable or unwilling to provide signed consent for participation

• and were unable or unwilling to meet study requirements for data collection and intervention purposes.

• Within the month immediately preceding the screening visit, use of any form of tobacco or nicotine products other than cigarettes (e.g., e-cigarettes, chewing tobacco, etc.) on 3 or more days within a week if the individual refuses to refrain from such tobacco use during the course of the study

• Current use of NRT or enrollment (or plans to enroll) in another smoking cessation program in the next 3 months

• Uncontrolled hypertension (systolic blood pressure [SBP] greater than 180 or diastolic blood pressure [DBP] greater than 110)

• History of severe cardiovascular (stroke, heart attack), kidney (e.g. chronic or acute kidney failure) or liver disease, or other unstable disease in the last 3 months

• History of hypersensitivity or allergic reaction to NRT or similar chemical classes or any component of these formulations (including allergy to latex)